After a lot of initial artificial Intelligence (AI) hype, many useful AI applications have been identified, and now AI is transforming many industrial areas. Pharma companies also realize the application of AI can positively disrupt the traditional business processes in various ways, such as smarter therapy target hunting, quicker drug candidate molecule generation, efficient non-clinical/ clinical development, and more precise drug market penetration. Currently many pharma companies are actively trying to apply AI technologies to their business. However, before AI implementation into their business processes, pharma companies need to make some decisions on how to approach to AI technologies, such as collaborations with AI companies or internal development of AI capabilities. In this session, points needed to be considered upon collaborations with AI companies from pharma perspectives will be discussed. Also, potential applications of AI to pharmaceutical business processes will be discussed including some real use cases.

To: 要旨(抄録)